In the survival analysis, we found that in ESCC, high expression of MYADM was associated with a worse survival rate, and low expression of MYADM was associated with a higher survival rate (P = 0.001, Figure 5H). The gene discussed is MYADM; the disease is esophageal squamous cell carcinoma.